Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
6.58
Dollar change
+0.18
Percentage change
2.81
%
Index- P/E- EPS (ttm)-1.37 Insider Own59.93% Shs Outstand17.42M Perf Week6.47%
Market Cap120.81M Forward P/E- EPS next Y-1.24 Insider Trans0.10% Shs Float7.36M Perf Month-0.75%
Income-22.38M PEG- EPS next Q-0.26 Inst Own8.53% Short Float14.62% Perf Quarter-11.32%
Sales0.00M P/S- EPS this Y20.28% Inst Trans28.38% Short Ratio10.65 Perf Half Y-33.33%
Book/sh0.76 P/B8.61 EPS next Y-8.33% ROA-124.61% Short Interest1.08M Perf Year-56.34%
Cash/sh1.06 P/C6.21 EPS next 5Y- ROE-170.23% 52W Range5.85 - 15.96 Perf YTD-21.10%
Dividend Est.- P/FCF- EPS past 5Y- ROI-159.62% 52W High-58.77% Beta0.45
Dividend TTM- Quick Ratio3.46 Sales past 5Y0.00% Gross Margin- 52W Low12.48% ATR (14)0.48
Dividend Ex-Date- Current Ratio3.46 EPS Y/Y TTM4.05% Oper. Margin0.00% RSI (14)51.46 Volatility6.10% 6.93%
Employees13 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price20.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q8.40% Payout- Rel Volume0.60 Prev Close6.40
Sales Surprise- EPS Surprise36.98% Sales Q/Q- EarningsMay 07 BMO Avg Volume101.03K Price6.58
SMA200.30% SMA500.25% SMA200-19.12% Trades Volume60,308 Change2.81%
Date Action Analyst Rating Change Price Target Change
Jul-13-22Initiated Ladenburg Thalmann Buy $21
May-28-24 06:10AM
May-24-24 09:55AM
May-16-24 08:30AM
May-07-24 09:06PM
01:53PM
08:00AM Loading…
08:00AM
Apr-08-24 08:30AM
Apr-02-24 04:30PM
Mar-19-24 08:00AM
Mar-15-24 08:00AM
Mar-14-24 09:00AM
Mar-05-24 11:52PM
08:31AM
08:00AM
Feb-09-24 08:32AM
08:00AM Loading…
08:00AM
Jan-03-24 08:00AM
Dec-18-23 08:00AM
Nov-08-23 08:00AM
Oct-24-23 08:00AM
Oct-16-23 09:35AM
Sep-25-23 07:30PM
Sep-21-23 08:00AM
Sep-12-23 08:00AM
Sep-06-23 08:00AM
Sep-01-23 08:00AM
Aug-17-23 08:00AM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 08:00AM
06:26AM Loading…
06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
07:23AM
Jul-20-23 06:55AM
06:55AM
Jul-19-23 07:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
06:50AM
Jul-13-23 07:02AM
07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
06:08AM
Jul-10-23 06:56AM
06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 07:13AM
06:58AM
Jun-27-23 06:46AM
06:46AM
Jun-26-23 06:41AM
Jun-21-23 07:20AM
Jun-20-23 08:00AM
06:35AM
Jun-18-23 08:03AM
Jun-05-23 08:50AM
Jun-01-23 04:48AM
May-31-23 06:22AM
May-19-23 08:50AM
May-15-23 09:55AM
08:00AM
May-10-23 08:00AM
May-09-23 01:34PM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 10:14AM
08:00AM
06:47AM
Apr-26-23 06:26AM
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-18-23 08:00AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 08:00AM
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RONChairman & CEOMay 14 '24Buy6.741,94013,0763,246,424May 15 09:16 AM
BENTSUR RONChairman & CEOMay 10 '24Buy6.402,00012,8003,244,484May 13 08:51 AM
Shemesh ShayChief Dev. & Ops. OfficerMay 10 '24Buy6.321,1137,0341,493,068May 13 08:47 AM
Poradosu EnriqueChief Science & Business OffMay 10 '24Buy6.295003,1451,504,319May 13 08:49 AM
BENTSUR RONChairman & CEOMar 18 '24Buy10.295,00051,4503,242,484Mar 19 08:00 AM
BENTSUR RONChairman & CEOOct 10 '23Buy11.086407,0913,237,484Oct 12 04:05 PM
BENTSUR RONChairman & CEOOct 09 '23Buy11.198309,2883,236,844Oct 10 08:30 AM
BENTSUR RONChairman & CEOOct 06 '23Buy11.272502,8183,236,014Oct 10 08:30 AM
BENTSUR RONChairman & CEOOct 05 '23Buy11.091,40015,5263,235,764Oct 06 08:37 AM
BENTSUR RONChairman & CEOOct 04 '23Buy10.951,82019,9293,234,364Oct 06 08:37 AM
BENTSUR RONChairman & CEOAug 16 '23Buy15.151151,7423,232,544Aug 16 04:05 PM
BENTSUR RONChairman & CEOAug 15 '23Buy14.342353,3703,232,429Aug 16 04:05 PM
BENTSUR RONChairman & CEOAug 11 '23Buy14.661802,6393,232,194Aug 11 06:07 PM
BENTSUR RONChairman & CEOAug 08 '23Buy14.831201,7803,232,014Aug 11 06:07 PM
Mosseri Marlio Charles10% OwnerJul 31 '23Buy13.8886011,9372,595,000Aug 01 08:00 AM
Mosseri Marlio Charles10% OwnerJul 28 '23Buy13.912,58435,9432,594,140Jul 31 08:00 AM
Mosseri Marlio Charles10% OwnerJul 27 '23Buy13.981,55621,7532,591,556Jul 28 08:00 AM
Mosseri Marlio Charles10% OwnerJul 26 '23Buy13.9710,000139,7002,590,000Jul 27 06:52 AM
Mosseri Marlio Charles10% OwnerJul 21 '23Buy14.612,84441,5512,580,000Jul 24 04:45 PM
BENTSUR RONChairman & CEOJul 21 '23Buy14.852253,3413,231,894Jul 24 04:45 PM
Mosseri Marlio Charles10% OwnerJul 20 '23Buy14.405,39477,6742,577,156Jul 24 04:45 PM
BENTSUR RONChairman & CEOJul 20 '23Buy15.061101,6573,231,669Jul 24 04:45 PM
Mosseri Marlio Charles10% OwnerJul 19 '23Buy14.848,000118,7202,571,762Jul 20 06:30 AM
BENTSUR RONChairman & CEOJul 19 '23Buy14.332002,8663,231,559Jul 20 06:30 AM
Mosseri Marlio Charles10% OwnerJul 18 '23Buy14.849,149135,7712,563,762Jul 19 08:06 AM